Under New Rule, Hospitals Will Have to Share Information on Pricing

The hospital rule is slated to go into effect in January 2021. (Heidi de Marco/KHN/TNS)

Hospitals will soon have to share price information they have long kept obscured — including how big a discount they offer cash-paying patients and rates negotiated with insurers — under a rule finalized Friday by the Trump administration.

In a companion proposal, the administration announced it is also planning to require health insurers to spell out beforehand for all services just how much patients may owe for out-of-pocket costs for all services. That measure is now open for public comment.

“What is more clear and sensible than Americans knowing what their care is going to cost before going to the doctor?” said Joe Grogan, director of the White House Domestic Policy Council.

The hospital rule is slated to go into effect in January 2021. But it is controversial and likely to face court challenges.

It is part of an effort by the Trump administration to increase price transparency in hopes of lowering health care costs on everything from hospital services to prescription drugs.

When that rule was first proposed in July, hospitals and insurers objected. They argued it would require them to disclose propriety information, could hamper negotiations and could backfire if some medical providers see they are underpriced compared with peers and raise their charges.

Shortly after the final rule’s release, four major hospital organizations said they would challenge it in court.

“This rule will introduce widespread confusion, accelerate anticompetitive behavior among health insurers and stymie innovations,” according a joint statement from these groups, which made clear their intent to soon “file a legal challenge to the rule on the grounds including that it exceeds the administration’s authority.” The statement was signed by the American Hospital Association, the Association of American Medical Colleges, the Children’s Hospital Association and the Federation of American Hospitals.

Insurers also pushed back. “The rules the administration released today will not help consumers better understand what health services will cost them and may not advance the broader goal of lowering health care costs,” said Scott Serota, president and CEO of the Blue Cross Blue Shield Association, in a statement.

Requiring disclosure of negotiated rates, he said, could lead to price increases “as clinicians and medical facilities could see in the negotiated payments a roadmap to bidding up prices rather than lowering rates.” The rule, he added, could confuse consumers.

It’s also a potentially crushing amount of data for a consumer to consider. However, the administration said it hopes the data will also spur researchers, employers or entrepreneurs to find additional ways of making the data accessible and useful.

The amount of information the rule requires to be disclosed will be massive — including gross charges, negotiated rates and cash prices among them — for every one of the thousands of services offered by every hospital, which they will be required to update annually.

In a nod to how hard it might be for a consumer to add up items from such an a la carte list of prices, the rule also requires each hospital to include a list of 300 “shoppable” services, described in plain language, with all the ancillary costs included. So, in effect, a patient could look up the total cost of a knee replacement, hernia repair or other treatment.

Insurers, under the proposed rule, would have to disclose the rates they negotiate with providers like hospitals. They would also be required to create online tools to calculate for individual consumers the amount of their estimated out-of-pocket costs for all services, including any deductible they may owe, and make that information available before the consumer heads to the hospital or doctor.

It would go into effect one year after it is finalized, although it is not known when that will occur.

Although consumer advocates say price information can help patients shop for lower-cost services, they also note that few consumers do, even when provided such information.

Earlier this year, the administration ordered drugmakers to include their prices in advertisements, but the industry sued and won a court ruling blocking the measure. The administration has appealed that ruling.

Nonetheless, Health and Human Services Secretary Alex Azar said the administration is confident.

“We may face litigation, but we feel we are on sound legal footing for what we are asking,” Azar said. “We hope hospitals respect patients’ right to know the prices of services and we’d hate to see them take a page out of Big Pharma’s playbook and oppose transparency.”

He and other officials on a call with reporters admitted they don’t have any estimates on how much the proposal would save in lowered costs because such a broad effort has never been tried in the U.S. before.

Still, “point me to one sector of the American economy where having pricing information actually leads to higher prices,” Azar said.

Azar cited some studies that show that when prices are disclosed, overall spending can go down because patients choose cheaper services. However, such efforts also generally require financial incentives for the patient, such as sharing in the cost savings.

The proposed rule for insurers urges them to create such incentives, said Seema Verma, who oversees the federal government’s Center for Medicare & Medicaid Services.

George Nation, a business professor at Lehigh University in Pennsylvania who studies hospital pricing, called the final rule and the insurer proposal “exactly a move in the right direction.”

Among other things, he said, the price information may prove useful to employers comparing whether their insurer or administrator is doing a good job in bargaining with local providers.

Today, “they just see a bill and a discount. But is it a good discount? This will now all be transparent,” Nation said.

———

Kaiser Health News (KHN) is a national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation which is not affiliated with Kaiser Permanente.

———

©2019 Kaiser Health News

Visit Kaiser Health News at www.khn.org

Distributed by Tribune Content Agency, LLC.


Notice: Undefined variable: pc_ID in /var/www/html/thewellnews/wp-content/themes/twentynineteen-child/template-parts/content/content-single.php on line 263


Notice: Undefined variable: primary_cat in /var/www/html/thewellnews/wp-content/themes/twentynineteen-child/template-parts/content/content-single.php on line 268

Blunt Won't Seek Senate Reelection in 2022
U.S. Senate
Blunt Won't Seek Senate Reelection in 2022
March 8, 2021
by TWN Staff

WASHINGTON - Sen. Roy Blunt, R-Mo., surprised many on Capitol Hill Monday by announcing he will not seek a third term in the U.S. Senate. Blunt was widely expected to seek a third term in 2022, but in a video announcment, he suggested the time had... Read More

WHO Cancels Interim Report on Origins of COVID-19 Amid Tensions
Geopolitics
WHO Cancels Interim Report on Origins of COVID-19 Amid Tensions
March 8, 2021
by Daniel Mollenkamp

A fiery open letter signed by an international collection of scientists together with growing tensions between China and the U.S. caused the World Health Organization investigators this week to cancel an interim report on the origins of the coronavirus based on investigations in China. The letter,... Read More

Supreme Court Rejects Final Trump Bid to Reverse 2020 Election
Supreme Court
Supreme Court Rejects Final Trump Bid to Reverse 2020 Election
March 8, 2021
by Dan McCue

WASHINGTON - The U.S. Supreme Court on Monday rejected a bid by former President Donald Trump to nullify his election loss in Wisconsin, rejecting the last remaining appeal seeking to overturn Joe Biden’s victory. In an unsigned order, the justices declined to take up Trump’s lawsuit... Read More

Nonprescription COVID-19 Test Approved by FDA
Health
Nonprescription COVID-19 Test Approved by FDA
March 8, 2021
by Daniel Mollenkamp

WASHINGTON - The Food and Drug Administration issued an emergency authorization for a non-prescription, over the counter nostril test for coronavirus, the agency announced on Friday.  It's the first over the counter molecular test they have authorized for use without a prescription.  It's also the latest... Read More

Executive Order Directs Agencies to Step Up Voting Rights Efforts
White House
Executive Order Directs Agencies to Step Up Voting Rights Efforts
March 8, 2021
by Dan McCue

WASHINGTON – Federal agencies must take steps to expand access to voter registration and give their employees time off to vote or volunteer as nonpartisan poll workers, a new executive order from the White House says. President Joe Biden signed the order Sunday as part of... Read More

Arizona Schools Must Offer In-Person Instruction
In The States
Arizona Schools Must Offer In-Person Instruction
March 8, 2021
by TWN Staff

PHOENIX - Arizona Gov. Doug Ducey issued an executive order last week requiring public schools to offer in-person, teacher-led instruction by Monday, March 15. According to the Republican governor, 12 of Arizona’s 15 counties are in phases where all schools are safe to open, including in... Read More

News From The Well
scroll top